A Comparative Study of the Pharmacokinetics of SIM0718 Injection in Healthy Adult Subjects in China
NCT06701149
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
178
Enrollment
OTHER
Sponsor class
Conditions
Healthy Adult Subjects
Interventions
DRUG:
Rademikibart injection
DRUG:
CBP-201 injection
Sponsor
Simcere Pharmaceutical Co., Ltd